Triazolo[4,5-d]pyrimidin-5-amines based ERK3 inhibitors fail to demonstrate selective effects on adipocyte function
А. Е. Белых(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego), Grzegorz Sumara(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego)
Cited by 2
Related Papers
The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation
|Genes & Development|2020|35
A phosphoproteomic approach reveals that PKD3 controls PKA-mediated glucose and tyrosine metabolism
|Life Science Alliance|2021|12